These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 789941)

  • 21. Inhibition of T-cell rosette formation by Hodgkin-disease serum.
    Siegal FP
    N Engl J Med; 1976 Dec; 295(23):1314-5. PubMed ID: 185518
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.
    Stein H; Lennert K; Feller AC; Mason DY
    Adv Cancer Res; 1984; 42():67-147. PubMed ID: 6395656
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 24. The surface antigenicity of serially transplantable malignant human lymphoid cells derived from subjects with infectious mononucleosis, Hodgkin's disease, chronic lymphatic leukemia, or acute lymphoblastic leukemia.
    Galli SJ; Adams RA
    Cancer Res; 1974 Feb; 34(2):298-303. PubMed ID: 4589952
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunological and clinical differences between lymphoblastic leukemia and lymphoma originating from non-T, non-B cells, T cells and B cells].
    Rupniewska ZM; Kniaź M
    Postepy Hig Med Dosw; 1980; 34(2):119-41. PubMed ID: 7017639
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunologic classification of non-Hodgkin's lymphomas: current status.
    Seligmann M; Brouet JC; Preud'homme JL
    Cancer Treat Rep; 1977 Sep; 61(6):1179-83. PubMed ID: 332351
    [No Abstract]   [Full Text] [Related]  

  • 27. Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non-Hodgkin's lymphomas).
    Mathé G; Belpomme D; Dantchev D; Pouillart P
    Biomedicine; 1975 May; 22(3):177-85. PubMed ID: 809067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of T and B lymphocytes in different chronic internal diseases with immune processes.
    Mihăilescu E; Micu D; Purice S; Ion V; Miron C; Sighetea E; Constantineanu M; Popescu R
    Med Interne; 1976; 14(3):205-10. PubMed ID: 1088212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Means of approaching a nosologic classification of lymph node sarcomas].
    Chelloul N
    Bull Cancer; 1974; 61(1):35-6. PubMed ID: 4617608
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic definition of lymphocytes: functions and markers.
    Stathopoulos G; Davies AJ
    Recent Results Cancer Res; 1976; (56):17-23. PubMed ID: 1087443
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunologic cell markers in lymphoproliferative diseases].
    Samoĭlova RS
    Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lymphoproliferative disease and immune deficiency syndrome].
    Shirakawa S
    Nihon Rinsho; 1974 Jun; 32(6):1221-36. PubMed ID: 4610218
    [No Abstract]   [Full Text] [Related]  

  • 34. HLA antigens on human peripheral lymphocytes and spleen of malignant lymphoma and other cancer patients.
    Cohen E; Kim U; Blumenson L; Gregory SG; Khurana U; Cox C
    Prog Clin Biol Res; 1977; 16():181-6. PubMed ID: 269456
    [No Abstract]   [Full Text] [Related]  

  • 35. The monoclonal nature of lymphatic leukemia.
    Seligmann M; Preud'homme JL; Brouet JC
    Birth Defects Orig Artic Ser; 1975; 11(1):163-70. PubMed ID: 50095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peripheral T- and B-lymphocytes after termination of a 2-year treatment using cytostatics in patients with acute lymphoblastic leukosis, lymphosarcoma and lymphogranulomatosis in full remission].
    Beck ID; Lemmel EM
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1600-3. PubMed ID: 1088527
    [No Abstract]   [Full Text] [Related]  

  • 37. [Reactivity of the lymphocytes of lymph nodes in cases of malignant lymphoma to plant agglutinin].
    Stramignoni A; Navone R; Meriggi E
    Boll Soc Ital Biol Sper; 1969 Feb; 45(3):194-6. PubMed ID: 4899663
    [No Abstract]   [Full Text] [Related]  

  • 38. Search for correlations between immunological and morphological criteria used to classify lymphoid leukemias and non-Hodgkin's hematosarcomas with special reference to scanning electron microscopy and T and B membrane markers.
    Belpomme D; Dantchev D; Karima AM; Lelarge N; Joseph R; Caillou B; Lafleur M; Mathé G
    Recent Results Cancer Res; 1976; (56):131-43. PubMed ID: 794955
    [No Abstract]   [Full Text] [Related]  

  • 39. Rosette-forming lymphocytes in Hodgkin's disease.
    Cohnen G; Augener W; Brittinger G; Douglas SD
    N Engl J Med; 1973 Oct; 289(16):863. PubMed ID: 4543492
    [No Abstract]   [Full Text] [Related]  

  • 40. PHA response of blood and lymph node lymphocytes in vitro in malignant lymphomas.
    Navone R; Stramignoni A
    Acta Haematol; 1974; 51(2):76-83. PubMed ID: 4217079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.